TABLE 1

Influence of dose, route, and pattern of exposure on DCE toxicokinetic parameter estimates

Rats were administered 10 or 30 mg/kg DCE as an oral bolus (p.o.) or over a 2-h period by constant gastric infusion (g.i.). Other groups of rats inhaled (inhal) 100 or 300 ppm DCE for 2 h. Serial arterial samples were taken for DCE analysis during and after exposures to characterize blood profiles. Values are means ± S.D. for groups of six rats.

DoseCmaxTmaxt1/2AUC02AUC0F
mg/lminμg · min/ml%
10 mg/kg p.o.2.2 ± 0.8a7 ± 5a47 ± 19a44 ± 15a51 ± 16a24.4
10 mg/kg g.i.0.2 ± 0.1b,A146 ± 34b,A78 ± 16a,A10 ± 3b,A33 ± 10a,A17.1
100 ppm inhal0.6 ± 0.1B55 ± 18B50 ± 24a,A62 ± 9B72 ± 10B39.4
30 mg/kg p.o.8.9 ± 4.1c5 ± 3a88 ± 29a222 ± 64c233 ± 8c46.5
30 mg/kg g.i.1.9 ± 0.7d,C128 ± 32b,C92 ± 38a,B89 ± 37d,C279 ± 107c,C40.1
300 ppm inhal2.8 ± 0.7D90 ± 35C50 ± 20a,B241 ± 57D279 ± 73c,C55.7
  • Values that are significantly different (p < 0.05) from one another are designated by different superscripts. Lowercase letters are used for comparison of p.o. and g.i. values, whereas uppercase letters are used for comparing g.i. and inhal data.